On Monday, Enhabit Inc. (NYSE: EHAB) defended its strategy of taking on more Medicare Advantage (MA) revenue over the last couple of years. It did so in yet another response to AREX Capital Management, an activist investor that owns 4.9% of Enhabit shares. Enhabit and AREX Capital – which wants to replace Enhabit’s current board members – have gone back and forth publicly over recent months. Specifically, the two have gone back and forth after Enhabit decided to remain a public, independent company after its strategic review.
Read the full article: Enhabit Defends Medicare Advantage Strategy, Overhead Costs //
Source: https://homehealthcarenews.com/2024/06/enhabit-defends-medicare-advantage-strategy-overhead-costs/